Breaking News

You are here » Indian-Commodity  :  Economy  :  India's pharma exports declined by 4% till August on pricing pressure


India's pharma exports declined by 4% till August on pricing pressure

India's pharmaceutical exports has registered a negative growth of 4 percent during the first five months of the financial year 2017-18, mainly due to increased regulatory issues along with pricing pressure in global markets. Udaya Bhaskar, the Director General of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), has said that the pharma exports to other countries declined by 7.9 percent during the April-July period, while recovered to 4 percent in the month of August leaving the overall growth at minus 4 percent till August this year.

Bhaskar has pointed out that pricing pressure is one of the factors for decline in exports. He also noted that factors such as import alerts by US Food and Drug Administration (USFDA) on Indian plants, regulatory issues and currency fluctuation, also contributed to downward growth. However, he hoped that the overall exports will recover and come into positive zone for the full year as exports are expected to take an uptick from September.

Pharmexcil's Director General further said that initially, rollout of Goods and Services Tax (GST) regime also created some confusion among the manufacturers leading to stoppage of production by some companies, but now they are seeing some growth. According to statistics, India exported $16.90 billion worth of pharma products during 2015-16 and the same was slightly declined to $16.64 billion in 2016-17.

Related News

View all news

India has potential to be $5 trillion economy in next 7-8 years: Suresh Prabhu

Expressing confidence over growth of Indian economy, Union Commerce and Civil Aviation Minister Suresh Prabhu stated that India has potential to be a $5 trillion economy in the next 7-8 years. He added......

Working group recommends measures to attain $5 trillion economy by 2025

In order to increase the size of India's economy to $5 trillion by 2025, a working group of the Commerce and Industry Ministry has come out with a blueprint suggesting a bunch of lengthy and short-term......

RBI to inject Rs 10,000 crore into the system through OMOs

In a bid to increase liquidity in the market, the Reserve Bank of India (RBI) has said that it will inject Rs 10,000 crore into the system through purchase of government securities on January 17, 2019.......

Top News

View all news

Glenmark Pharma recalling 96,240 applicators of its product from US

Glenmark Pharmaceuticals is recalling 96,240 applicators of its product Estradiol vaginal inserts for defective delivery system. The USFDA has termed it as a Class-II recall. The USFDA has classified Class-II......

Infosys hires over 7,600 staff in US

Infosys has hired over 7,600 staff in the US. This hiring is more than three-fourth of its target of recruiting 10,000 American workers. The company is making recruitment from local schools a 'sustained......

SBI to sell 26% stake of SBI payment services

State Bank of India (SBI) is planning to sell 26% stake of its SBI payment services (SPSPL) to Hitachi Payment Services (HPY). After allotment of the shares, SBI shareholding in SPSPL will become 74% from......